Spouting Rock Asset Management, LLC Coherus Bio Sciences, Inc. Transaction History

Spouting Rock Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$15.81 - $18.99 $234,414 - $281,564	-14,827 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $1,876 - $2,632	-148 Reduced 0.99%	14,827 $238,000
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $153,094 - $182,177	-11,822 Reduced 44.12%	14,975 $207,000
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $386,412 - $573,187	26,797 New	26,797 $392,000

137

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $96.4M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.